Lifecore Biomedical Inc (LFCR)
5.87
+0.10
(+1.73%)
USD |
NASDAQ |
May 17, 16:00
5.85
-0.02
(-0.34%)
After-Hours: 20:00
Lifecore Biomedical Total Assets (Quarterly): 255.15M for May 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
May 31, 2023 | 253.54M |
February 28, 2023 | 236.15M |
November 30, 2022 | 279.07M |
August 31, 2022 | 285.80M |
May 31, 2022 | 274.70M |
February 28, 2022 | 325.58M |
November 30, 2021 | 422.12M |
August 31, 2021 | 445.62M |
May 31, 2021 | 502.92M |
February 28, 2021 | 509.82M |
November 30, 2020 | 499.16M |
August 31, 2020 | 506.18M |
May 31, 2020 | 541.31M |
February 29, 2020 | 550.06M |
November 30, 2019 | 560.00M |
August 31, 2019 | 546.14M |
May 31, 2019 | 519.09M |
February 28, 2019 | 501.58M |
November 30, 2018 | 411.65M |
August 31, 2018 | 402.90M |
May 31, 2018 | 404.70M |
February 28, 2018 | 385.84M |
November 30, 2017 | 379.31M |
August 31, 2017 | 366.97M |
May 31, 2017 | 358.61M |
Date | Value |
---|---|
February 28, 2017 | 346.14M |
November 30, 2016 | 341.34M |
August 31, 2016 | 343.77M |
May 31, 2016 | 342.65M |
February 29, 2016 | 328.68M |
November 30, 2015 | 361.10M |
August 31, 2015 | 342.58M |
May 31, 2015 | 346.46M |
February 28, 2015 | 340.30M |
November 30, 2014 | 341.10M |
August 31, 2014 | 325.94M |
May 31, 2014 | 313.62M |
February 28, 2014 | 306.78M |
November 30, 2013 | 302.26M |
August 31, 2013 | 290.83M |
May 31, 2013 | 290.94M |
February 28, 2013 | 283.00M |
November 30, 2012 | 278.11M |
August 31, 2012 | 267.96M |
May 31, 2012 | 277.69M |
February 29, 2012 | 211.55M |
November 30, 2011 | 209.41M |
August 31, 2011 | 208.89M |
May 31, 2011 | 206.31M |
February 28, 2011 | 208.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
236.15M
Minimum
Feb 2023
560.00M
Maximum
Nov 2019
426.90M
Average
499.16M
Median
Nov 2020
Total Assets (Quarterly) Benchmarks
Aquestive Therapeutics Inc | 129.52M |
SELLAS Life Sciences Group Inc | 24.43M |
ADMA Biologics Inc | 350.88M |
Relmada Therapeutics Inc | 84.41M |
Jaguar Health Inc | 55.39M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 256.99M |
Shareholders Equity (Quarterly) | -1.842M |